How Next-Generation Sequencing is Reshaping Cancer Research in Advanced Science

Cancer is the leading cause of death worldwide, accounting for 10 million deaths by 2020.¹ Prostate cancer is the second leading cause of cancer-related death among American men, second only to lung cancer.²

Join our upcoming webinar hosted by Dr. Nallasivam Palanisamy, Henry Ford Health and Zachary Herbert, Dana-Farber Cancer Institute, as they explore the rapidly growing role of next-generation sequencing (NGS) in revolutionizing cancer research.

Speakers will explore the importance of NGS technology in unraveling the mysteries of cancer. With a focus on prostate cancer, the webinar will highlight transcriptomic signatures—an approach that is beginning to illuminate the genetic nuances underlying cancer disparities, particularly in African American men. The transformative potential of transcriptomic analysis will be demonstrated and insight into recent advances and their implications for cancer treatment.

Furthermore, how automation is changing the landscape of cancer research will also be explored. By pioneering automation technology, researchers can now control test volume and reduce turnaround times, accelerating the speed of discovery. This new approach will be demonstrated with experimental data demonstrating the successful use of RNAse1/hybrid capture in the current project.

Dr. Nallasivam Palanisamy is an Associate Scientist in the Department of Urology at Henry Ford Health. Palanisamy specializes in prostate cancer, cancer genomics, and molecular cytogenetics/molecular pathology. His research interests are in finding and characterizing gene expression in cancer and understanding their role in carcinogenesis from a translational research perspective.

Zachary Herbert is Director of the Molecular Biology Core Facilities, Lead Scientist at the Dana-Farber Cancer Institute, and Associate Director of the Harvard University Center for AIDS Research Advanced Laboratory Technologies Core. His laboratory focuses primarily on the development and implementation of NGS sample preparation, sequencing, and bioinformatics services to advance basic and translational research. He has a BA in Molecular Biology and Biochemistry, a Master’s in Biotechnology, and 20 years of experience running an advanced genomics center.

1. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon: International Agency for Research on Cancer; 2020. Available at URL: https://gco.iarc.fr/today?
2. American Cancer Society Atlanta, Ga. 2023. Available at URL: https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html??

Main learning objectives

• Explore the practical application of FFPE RNA to NGS in cancer research
• Learn more about the identification of a key gene driving prostate cancer in African Americans, to aid understanding of racial disparities in the workforce
• Discover the role of automated NGS workflows in accelerating tumor biology knowledge

Who should go?

• An educational institution
• Government research
• Organic contract research
• Hospitals
• In medicine
• Pharma
• Biotechnology
• Medical facilities

Certificate of attendance

All web participants can request a certificate of attendance, including a summary of learning outcomes, for continuing education purposes.

Beckman Coulter Life Sciences